Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles

Diabetes, Obesity and Metabolism

Volumn 14, Issue 4, 2012, Pages 358-364

  Yang, J ^a   Sun, H ^a   Song, C ^a  

^a INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

Author keywords

Diabetes mellitus; Glycaemic control; Insulin delivery; Nanoparticles; Oral insulin

Indexed keywords

GLUCOSE; INSULIN; NANOPARTICLE; POLY(LACTIC CO GLYCOLIC ACID) NANOPARTICLE; POLYGLACTIN; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG;

ACIDITY; ALKALINITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG EFFICACY; DRUG RELEASE; DRUG SYNTHESIS; EMULSION; EVAPORATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; NANOENCAPSULATION; NONHUMAN; PH; RAT;

EID: 84862777284     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01546.x     Document Type: Article

References (24)

1. Gale EA. Two cheers for inhaled insulin. Lancet 2001; 357: 324-325.
2. Trehan A, Ali A. Recent approaches in insulin delivery. Drug Dev Ind Pharm 1998; 90: 589-597.
3. Damge C, Vranckx H, Balschimidt P, Couvreur P. Poly(alkyl cyanoacrylate nanospheres for oral administration of insulin). J Pharm Sci 1997; 86: 403-409.
4. Heinemann L, Weyer C, Rauhaus M, Heinrichs S, Heise T. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart. Diabetes Care 1998; 21: 1910-1914.
5. Heise T, Nosek L, Ronn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes 2004; 53: 1614-1620.
6. Kennedy FP. Recent developments in insulin delivery techniques: current status and future potential. Drugs 1991; 42: 213-227.
7. Owens DR, Zinman B, Bolli G. Alternative routes of insulin delivery. Diabet Med 2003; 20: 886-898.
8. Chalasani KB, Russell-Jones GJ, Yandrapu SK, Diwan PV, Jain SK. A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin. J Control Release 2007; 3: 421-429.
9. Onuki Y, Morishita M, Takayama K. Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery. J Control Release 2004; 97: 91-99.
10. Toorisaka E, Ono H, Arimori K, Kamiya N, Goto M. Hypoglycemic effect of surfactant - coated insulin solubilized in an novel solid-in-oil-in-water (S/O/W) emulsion. Int J Pharm 2003; 252: 271-274.
11. Morcol T, Nagappan P, Narenbaum L, Mitchell A, Bell SJD. Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin. Int J Pharm 2004; 277: 91-97.
12. Zhenqing H, Zhenxi Z, Chuanxin Z, Mei H. Use of natural plant exudates (Sanguis draxonis) for sustained oral insulin delivery with dramatic reductions of glycemic effects in diabetic rats. J Control Release 2004; 97: 467-475.
13. Cui F, Shi K, Zhang L, Tao A, Kawashima Y. Biodegradable nanoparticles loaded with insulin phospholipid complex for oral delivery: preparation, in vitro characterization and invivo evaluation. J Control Release 2006; 114: 242-250.
14. Damage C, Michel C, Aprahamian M, Couvreur P. New approach for the oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 1988; 37: 246-251.
15. Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002; 6: 319-327.
16. Thompson CJ, Tetlev L, Uchegbu IF, Cheng WP. The complexation between novel comb shaped amphiphilic polyallylamine and insulin-Towards oral insulin delivery. Int J Pharm 2009; 376: 46-55.
17. Ma Z, Lim TM, Lim L-Y. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Int J Pharm 2005; 293: 271-280.
18. Gaumet M, Gurny R, Delie F. Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size. Eur J Pharm Sci 2009; 36: 465-473.
19. Vert M, Schwach G, Engel R, Goudane J. Something new in the field of PLA/GA bioresorbable polymers. J Control Release 1998; 53: 85-92.
20. Lee HC, Kim SJ, Kin KS, Shin HC, Yoon JW. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 2000; 408: 483-488.
21. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997; 28: 5-24.
22. Li S. Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J Biomed Mater Res 1999; 48: 342-353.
23. Erden N, Celebi N. Factors influencing release of salbutamol sulphate from poly(lactide-co-glycolide) microspheres prepared by water-in-oil-in-water emulsion technique. Int J Pharm 1996; 137: 57-66.
24. Brange J, Langkjaer L. Chemical stability of insulin influence of excipients formulation and PH. Acta Pharm Nord 1992; 4: 149.